Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimens.
Yamada T, Terazaki Y, Sakamoto S, Yoshiyama K, Matsueda S, Komatsu N, Waki K, Yamada A, Kawahara A, Kage M, Sugawara S, Yamashita Y, Sasada T, Takamori S, Itoh K.
Yamada T, et al. Among authors: waki k.
Int J Oncol. 2015 Jan;46(1):55-62. doi: 10.3892/ijo.2014.2699. Epub 2014 Oct 7.
Int J Oncol. 2015.
PMID: 25310280
Clinical Trial.